HOWL FY 2022 Earnings — Werewolf Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

HOWLWerewolf Therapeutics, Inc.

$35M

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$16M

Gross Profit

$14M84.7% margin

Operating Income

-$56M-341.8% margin

Net Income

-$54M-328.1% margin

EPS (Diluted)

$-1.86

Cash Flow

Operating Cash Flow

-$41M

Free Cash Flow

-$44M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$160M

Total Liabilities

$38M

Stockholders' Equity

$122M

Cash & Equivalents

$129M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$16M	$0	—
Gross Profit	$14M	$0	—
Operating Income	-$56M	-$50M	-11.9%
Net Income	-$54M	-$50M	-7.7%